Alikhani Radin, Horbal Steven R, Rothberg Amy E, Pai Manjunath P
Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA.
Clin Transl Sci. 2024 Dec;17(12):e70062. doi: 10.1111/cts.70062.
Chronological age has been the standard for quantifying the aging process. While it is simple to quantify it cannot fully discern the biological variability of aging between individuals. The growing body of interest in this variability of human aging has led to the introduction of new biomarkers to operationalize biological age. The inclusion of body composition may provide additional value to biological aging as a prediction and estimation factor of individual health outcomes. Diagnostic images based on radiomic techniques such as Computed Tomography contain an untapped wealth of patient-specific data that remain inaccessible to healthcare providers. These images are beneficial for collecting information from body composition that adds precision and granularity when compared to traditional measures. This information can subsequently be aggregated to construct models for changes in the human body associated with aging. In addition, aging leads to a natural decline in the best parameter of drug dosing in older adults, glomerular filtration rate. Since the conventional models of kidney function are correlated with age and body composition, the radiomic biomarkers representing age-related changes in body composition may also serve as potential new imaging biomarkers of kidney function for personalized dosing. Our review introduces potential radiomic biomarkers as measures of body composition change targeting the aging processes. As a functional example, we have hypothesized an age-related model of radiomics as a covariate of kidney function to improve personalized dosing. Future research focusing on evaluating this hypothesis in human subject studies is acknowledged.
实际年龄一直是量化衰老过程的标准。虽然它易于量化,但无法完全识别个体间衰老的生物学差异。人们对人类衰老这种差异的兴趣日益浓厚,这导致引入了新的生物标志物来实现生物年龄的量化。纳入身体成分可能为生物衰老提供额外价值,作为个体健康结果的预测和评估因素。基于计算机断层扫描等放射组学技术的诊断图像包含大量尚未开发的患者特异性数据,医疗保健提供者无法获取这些数据。与传统测量方法相比,这些图像有助于从身体成分中收集信息,增加了精确性和粒度。随后可以汇总这些信息,构建与衰老相关的人体变化模型。此外,衰老会导致老年人最佳药物剂量参数——肾小球滤过率自然下降。由于传统的肾功能模型与年龄和身体成分相关,代表身体成分年龄相关变化的放射组学生物标志物也可能作为潜在的肾功能新成像生物标志物用于个性化给药。我们的综述介绍了潜在的放射组学生物标志物,作为针对衰老过程的身体成分变化测量指标。作为一个功能示例,我们假设了一个放射组学的年龄相关模型,作为肾功能的协变量以改善个性化给药。未来聚焦于在人体研究中评估这一假设的研究值得关注。